LLY compared with ANIP: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ANIPANI Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ANIPANI Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ANIP

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−2.83%—

Q2 FY26±8.4%▼−5.30%×0.63

= impliedLLY realized, solidANIP realized, hatchedOne scale, both sides: full bar = 12%× = |realized| ÷ impliedSource: market data

May 8 '26

±8.2%

▼−2.44%

×0.29

Q1 FY26±11.5%▼−4.21%×0.37

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ANIPANI Pharmaceuticals Inc

67.43▼−3.14%· post 67.44

ClosedNov 6 '26

Mkt cap$1.5BRevenue$291MQ3 FY26Revenue$883MFY25

Compare

ClosedNov 6 '26

LLYELI Lilly & Co

ANIPANI Pharmaceuticals Inc

1,360.90▼−0.28%post 1,358.90

Price

67.43▼−3.14%post 67.44

$1.2T

Mkt cap

$1.5B

Q3 FY26$24.4B

Revenue

$291MQ3 FY26

FY25$65.2B

Revenue

$883MFY25

LLY1,360.90▼−0.28%vsANIP67.43▼−3.14%ClosedNov 6 '26